Siemens Healthineers AG Unsponsored ADR(SMMNY)
$24.04+0.21 (+0.90%)
SMMNY
Siemens Healthineers AG Unsponsored ADR financials statements
$24.04
At close:+0.21 (+0.90%)
Want to see SMMNY full AI Analyst Report?
Siemens Healthineers AG Unsponsored ADR (SMMNY) Ratios
6 Followers
Siemens Healthineers AG Unsponsored ADR Ratios
SMMNY's free cash flow for Q4 2026 was €703.00M. For the 2026 fiscal year, SMMNY's free cash flow was decreased by €-288.00M and operating cash flow was €769.46M. See a summary of the company’s cash flow.
| Ratios | Sep 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.18 | 1.11 | 1.25 | 1.05 | 1.11 |
| Quick Ratio | 0.84 | 0.84 | 0.89 | 0.73 | 0.78 |
| Cash Ratio | 0.19 | 0.15 | 0.23 | 0.12 | 0.12 |
| Solvency Ratio | 0.13 | 0.11 | 0.11 | 0.11 | 0.12 |
| Operating Cash Flow Ratio | 0.25 | 0.20 | 0.21 | 0.13 | 0.19 |
| Short-Term Operating Cash Flow Coverage | 1.01 | 0.66 | 0.90 | 0.41 | 0.79 |
| Net Current Asset Value | € -11.14B | € -14.31B | € -13.36B | € -14.41B | € -15.82B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.34 | 0.35 | 0.36 | 0.34 |
| Debt-to-Equity Ratio | 0.76 | 0.83 | 0.89 | 0.92 | 0.84 |
| Debt-to-Capital Ratio | 0.43 | 0.46 | 0.47 | 0.48 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.37 | 0.38 | 0.42 | 0.40 | 0.40 |
| Financial Leverage Ratio | 2.35 | 2.46 | 2.53 | 2.58 | 2.47 |
| Debt Service Coverage Ratio | 1.05 | 0.77 | 1.13 | 0.72 | 1.19 |
| Interest Coverage Ratio | 7.83 | 8.08 | 6.93 | 8.24 | 25.97 |
| Debt to Market Cap | 0.36 | 0.33 | 0.26 | 0.30 | 0.33 |
| Interest Debt Per Share | 6.91 | 8.08 | 7.47 | 7.57 | 7.47 |
| Net Debt to EBITDA | 2.78 | 3.59 | 3.20 | 3.97 | 3.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.57% | 38.63% | 37.87% | 35.56% | 37.47% |
| EBIT Margin | 13.96% | 14.07% | 13.42% | 10.24% | 13.43% |
| EBITDA Margin | 18.98% | 19.61% | 18.89% | 17.43% | 19.61% |
| Operating Profit Margin | 13.52% | 14.70% | 14.76% | 11.25% | 14.11% |
| Pretax Profit Margin | 12.23% | 12.20% | 11.28% | 8.89% | 12.89% |
| Net Profit Margin | 9.37% | 9.17% | 8.68% | 6.96% | 9.39% |
| Continuous Operations Profit Margin | 9.50% | 9.28% | 8.76% | 7.03% | 9.46% |
| Net Income Per EBT | 76.61% | 75.16% | 76.97% | 78.27% | 72.79% |
| EBT Per EBIT | 90.48% | 83.05% | 76.45% | 79.02% | 91.38% |
| Return on Assets (ROA) | 4.74% | 3.88% | 4.22% | 3.23% | 4.15% |
| Return on Equity (ROE) | 11.15% | 9.53% | 10.67% | 8.35% | 10.27% |
| Return on Capital Employed (ROCE) | 9.54% | 8.69% | 9.57% | 7.34% | 8.27% |
| Return on Invested Capital (ROIC) | 6.75% | 5.88% | 6.88% | 5.13% | 5.64% |
| Return on Tangible Assets | 9.73% | 8.29% | 9.10% | 7.24% | 9.58% |
| Earnings Yield | 5.25% | 3.91% | 3.23% | 2.81% | 4.13% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.26 | 2.58 | 3.10 | 2.90 | 3.07 |
| Payables Turnover | 5.68 | 5.01 | 6.54 | 6.34 | 5.86 |
| Inventory Turnover | 3.21 | 3.31 | 3.32 | 3.25 | 3.39 |
| Fixed Asset Turnover | 4.62 | 4.67 | 5.00 | 5.15 | 5.08 |
| Asset Turnover | 0.51 | 0.42 | 0.49 | 0.46 | 0.44 |
| Working Capital Turnover Ratio | 11.42 | 9.62 | 12.54 | 21.14 | 21.46 |
| Cash Conversion Cycle | 161.47 | 178.89 | 171.53 | 180.63 | 164.28 |
| Days of Sales Outstanding | 112.03 | 141.41 | 117.60 | 126.00 | 118.74 |
| Days of Inventory Outstanding | 113.70 | 110.30 | 109.78 | 112.18 | 107.78 |
| Days of Payables Outstanding | 64.27 | 72.83 | 55.85 | 57.55 | 62.24 |
| Operating Cycle | 225.74 | 251.72 | 227.37 | 238.18 | 226.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.47 | 1.30 | 1.11 | 0.81 | 1.00 |
| Free Cash Flow Per Share | 1.10 | 0.95 | 0.79 | 0.43 | 0.63 |
| Dividend Paid and CapEx Coverage Ratio | 1.68 | 1.64 | 1.40 | 0.95 | 1.25 |
| Capital Expenditure Coverage Ratio | 3.90 | 3.77 | 3.55 | 2.16 | 2.65 |
| Operating Cash Flow Coverage Ratio | 0.22 | 0.16 | 0.15 | 0.11 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.13 | 0.11 | 0.08 | 0.10 |
| Free Cash Flow Yield | 5.80% | 4.13% | 2.95% | 1.81% | 2.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.01 | 25.62 | 30.93 | 35.53 | 24.20 |
| Price-to-Sales (P/S) Ratio | 1.79 | 2.34 | 2.69 | 2.47 | 2.27 |
| Price-to-Book (P/B) Ratio | 2.13 | 2.44 | 3.30 | 2.97 | 2.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.25 | 24.19 | 33.88 | 55.22 | 35.13 |
| Price-to-Operating Cash Flow Ratio | 12.83 | 17.77 | 24.33 | 29.64 | 21.86 |
| Price-to-Earnings Growth (PEG) Ratio | 1.80 | 7.43 | 1.07 | -1.38 | 1.52 |
| Enterprise Value Multiple | 12.18 | 15.54 | 17.42 | 18.17 | 15.15 |
| Enterprise Value | 54.63B | 67.16B | 73.59B | 68.63B | 64.53B |
| EV to EBITDA | 12.18 | 15.54 | 17.42 | 18.17 | 15.15 |
| EV to Sales | 2.31 | 3.05 | 3.29 | 3.17 | 2.97 |
| EV to Free Cash Flow | 22.34 | 31.46 | 41.51 | 70.68 | 45.96 |
| EV to Operating Cash Flow | 16.62 | 23.11 | 29.81 | 37.94 | 28.60 |
| Tangible Book Value Per Share | -1.81 | -2.91 | -2.90 | -3.44 | -3.53 |
| Shareholders’ Equity Per Share | 8.90 | 9.46 | 8.15 | 8.08 | 8.83 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.24 | 0.22 | 0.21 | 0.27 |
| Revenue Per Share | 10.60 | 9.84 | 10.02 | 9.68 | 9.67 |
| Net Income Per Share | 0.99 | 0.90 | 0.87 | 0.67 | 0.91 |
| Tax Burden | 0.77 | 0.75 | 0.77 | 0.78 | 0.73 |
| Interest Burden | 0.88 | 0.87 | 0.84 | 0.87 | 0.96 |
| Research & Development to Revenue | 0.08 | 0.08 | 0.09 | 0.09 | 0.08 |
| SG&A to Revenue | 0.17 | 0.16 | 0.15 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.47 | 1.44 | 1.27 | 1.20 | 1.11 |
Currency in EUR

